RecruitingNot ApplicableNCT06950203

The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

A Randomised, Double Blinded Study to Determine the Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality in Healthy Men.


Sponsor

Epax Norway AS

Enrollment

80 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The study will enrol men that have a poor sperm quality. They will take either a placebo or fish oil capsule (2 per day) for 3 months. At the beginning and end of the study the participant will be asked for a sperm sample for measuring quality parameters.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Comparator arm (DHA) and Very Long Chain Polyunsaturated Fatty Acids for people with infertility, male. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTVery Long Chain Polyunsaturated Fatty Acids

Fish oil with DHA and VLCPUFA

DIETARY_SUPPLEMENTComparator arm (DHA)

Oil containing equal DHA content to active arm


Locations(1)

Medicus Group AS

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06950203


Related Trials